Search research articles
Contact Us
Filters
Showing results (1671-1680 of 1,873) with videos related to
Page
of 188
Sort By:
European Journal of Heart Failure
|
November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial
Morten Schou, Brian Claggett, Zi Michael Miao, et al.
Circulation. Heart Failure
|
September 29, 2024
Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF
Misato Chimura, Mark C Petrie, Morten Schou, et al.
JACC. Heart Failure
|
June 9, 2023
Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status
Alexander Peikert, Parag Goyal, Muthiah Vaduganathan, et al.
JAMA Cardiology
|
November 17, 2024
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical Trials
Ankeet S Bhatt, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
European Journal of Heart Failure
|
April 11, 2026
Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial
Yasuhiro Hamatani, John W Ostrominski, Henri Lu, et al.
Journal of the American College of Cardiology
|
July 5, 2023
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure
Kieran F Docherty, Kirsty McDowell, Paul Welsh, et al.
JACC. Heart Failure
|
February 7, 2021
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists: An Analysis of DAPA-HF
Li Shen, Søren Lund Kristensen, Olof Bengtsson, et al.
Journal of the American College of Cardiology
|
May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
Carolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.
European Journal of Heart Failure
|
February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial
Ninian N Lang, Faheem A Ahmad, John G Cleland, et al.
JAMA Cardiology
|
November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical Trial
Finnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Page
of 188
Search research articles
Search
Showing results (1671-1680 of 1,873) with videos related to
Sort By:
Page
of 188
European Journal of Heart Failure
|
November 7, 2023
Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial
Morten Schou, Brian Claggett, Zi Michael Miao, et al.
Circulation. Heart Failure
|
September 29, 2024
Finerenone Improves Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction Irrespective of Age: A Prespecified Analysis of FINEARTS-HF
Misato Chimura, Mark C Petrie, Morten Schou, et al.
JACC. Heart Failure
|
June 9, 2023
Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status
Alexander Peikert, Parag Goyal, Muthiah Vaduganathan, et al.
JAMA Cardiology
|
November 17, 2024
Electronic Nudges and Influenza Vaccination Among Patients With a History of Myocardial Infarction: Insights From 3 Nationwide Randomized Clinical Trials
Ankeet S Bhatt, Niklas Dyrby Johansen, Muthiah Vaduganathan, et al.
European Journal of Heart Failure
|
April 11, 2026
Effects of Finerenone Across a Range of Heart Failure Duration: A Prespecified Analysis of the FINEARTS-HF Trial
Yasuhiro Hamatani, John W Ostrominski, Henri Lu, et al.
Journal of the American College of Cardiology
|
July 5, 2023
Association of Carbohydrate Antigen 125 on the Response to Dapagliflozin in Patients With Heart Failure
Kieran F Docherty, Kirsty McDowell, Paul Welsh, et al.
JACC. Heart Failure
|
February 7, 2021
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists: An Analysis of DAPA-HF
Li Shen, Søren Lund Kristensen, Olof Bengtsson, et al.
Journal of the American College of Cardiology
|
May 30, 2020
Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy
Carolyn Y Ho, Matthew E Mealiffe, Richard G Bach, et al.
European Journal of Heart Failure
|
February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trial
Ninian N Lang, Faheem A Ahmad, John G Cleland, et al.
JAMA Cardiology
|
November 3, 2022
Dapagliflozin and Kidney Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Analysis of the DELIVER Randomized Clinical Trial
Finnian R Mc Causland, Brian L Claggett, Muthiah Vaduganathan, et al.
Page
of 188